|
1
|
Raimondi S, Maisonneuve P and Lowenfels
AB: Epidemiology of pancreatic cancer: An overview. Nat Rev
Gastroenterol Hepatol. 6:699–708. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Colombet M, Soerjomataram I,
Dyba T, Randi G, Bettio M, Gavin A, Visser O and Bray F: Cancer
incidence and mortality patterns in europe: Estimates for 40
countries and 25 major cancers in 2018. Eur J Cancer. 103:356–387.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bosetti C, Bertuccio P, Negri E, La
Vecchia C, Zeegers MP and Boffetta P: Pancreatic cancer: Overview
of descriptive epidemiology. Mol Carcinog. 51:3–13. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kamisawa T, Wood LD, Itoi T and Takaori K:
Pancreatic cancer. Lancet. 388:73–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim D, Zhu H, Nassri A, Mokdad A, Kukreja
S, Polanco P, Huerta S and Ramzan Z: Survival analysis of veteran
patients with pancreatic cancer. J Dig Dis. 17:399–407. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lakatos G, Balázs A, Kui B, Gódi S, Szücs
Á, Szentesi A, Szentkereszty Z, Szmola R, Kelemen D, Papp R, et al:
Pancreatic cancer: Multicenter prospective data collection and
analysis by the hungarian pancreatic study group. J Gastrointestin
Liver Dis. 25:219–225. 2016.PubMed/NCBI
|
|
8
|
Burris HA III, Moore MJ, Andersen J, Green
MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo
AM, Tarassoff P, et al: Improvements in survival and clinical
benefit with gemcitabine as first-line therapy for patients with
advanced pancreas cancer: A randomized trial. J Clin Oncol.
15:2403–2413. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matsuda T and Matsuda A: Five-year
relative survival rate of pancreas cancer in the USA, Europe and
Japan. Jpn J Clin Oncol. 44:398–399. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Do Van B, Gouel F, Jonneaux A, Timmerman
K, Gelé P, Pétrault M, Bastide M, Laloux C, Moreau C, Bordet R, et
al: Ferroptosis, a newly characterized form of cell death in
parkinson's disease that is regulated by PKC. Neurobiol Dis.
94:169–178. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu B, Chen XB, Ying MD, He QJ, Cao J and
Yang B: The role of ferroptosis in cancer development and treatment
response. Front Pharmacol. 8:9922017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xie Y, Song X, Sun X, Huang J, Zhong M,
Lotze MT, Zeh HJ Rd, Kang R and Tang D: Identification of baicalein
as a ferroptosis inhibitor by natural product library screening.
Biochem Biophys Res Commun. 473:775–780. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Eling N, Reuter L, Hazin J, Hamacher-Brady
A and Brady NR: Identification of artesunate as a specific
activator of ferroptosis in pancreatic cancer cells. Oncoscience.
2:517–532. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kasukabe T, Honma Y, Okabe-Kado J, Higuchi
Y, Kato N and Kumakura S: Combined treatment with cotylenin a and
phenethyl isothiocyanate induces strong antitumor activity mainly
through the induction of ferroptotic cell death in human pancreatic
cancer cells. Oncol Rep. 36:968–976. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie Y, Hou W, Song X, Yu Y, Huang J, Sun
X, Kang R and Tang D: Ferroptosis: Process and function. Cell Death
Differ. 23:369–379. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Latunde-Dada GO: Ferroptosis: Role of
lipid peroxidation, iron and ferritinophagy. Biochim Biophys Acta
Gen Subj. 1861:1893–1900. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dixon SJ and Stockwell BR: The role of
iron and reactive oxygen species in cell death. Nat Chem Biol.
10:9–17. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Torti SV and Torti FM: Cellular iron
metabolism in prognosis and therapy of breast cancer. Crit Rev
Oncog. 18:435–448. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kazan HH, Urfali-Mamatoglu C and Gunduz U:
Iron metabolism and drug resistance in cancer. Biometals.
30:629–641. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Torti SV and Torti FM: Iron and cancer:
More ore to be mined. Nat Rev Cancer. 13:342–355. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang WS, SriRamaratnam R, Welsch ME,
Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji
AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by
GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cao JY and Dixon SJ: Mechanisms of
ferroptosis. Cell Mol Life Sci. 73:2195–2209. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yagoda N, von Rechenberg M, Zaganjor E,
Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM,
Boniface JJ, et al: RAS-RAF-MEK-dependent oxidative cell death
involving voltage-dependent anion channels. Nature. 447:864–868.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lemasters JJ: Evolution of
voltage-dependent anion channel function: From molecular sieve to
governator to actuator of ferroptosis. Front Oncol. 19:3032017.
View Article : Google Scholar
|
|
26
|
Thomas T and Thomas TJ: Polyamine
metabolism and cancer. J Cell Mol Med. 7:113–126. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu W, Zhang C, Wu R, Sun Y, Levine A and
Feng Z: Glutaminase 2, a novel p53 target gene regulating energy
metabolism and antioxidant function. Proc Natl Acad Sci USA.
107:7455–7460. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kang R, Kroemer G and Tang D: The tumor
suppressor protein p53 and the ferroptosis network. Free Radic Biol
Med. 133:162–168. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Linkermann A, Skouta R, Himmerkus N, Mulay
SR, Dewitz C, De Zen F, Prokai A, Zuchtriegel G, Krombach F, Welz
PS, et al: Synchronized renal tubular cell death involves
ferroptosis. Proc Natl Acad Sci USA. 111:16836–16841. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yuan H, Li X, Zhang X, Kang R and Tang D:
Identification of ACSL4 as a biomarker and contributor of
ferroptosis. Biochem Biophys Res Commun. 478:1338–1343. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gao M, Monian P, Quadri N, Ramasamy R and
Jiang X: Glutaminolysis and transferrin regulate ferroptosis. Mol
Cell. 59:298–308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lőrincz T, Jemnitz K, Kardon T, Mandl J
and Szarka A: Ferroptosis is involved in acetaminophen induced cell
death. Pathol Oncol Res. 21:1115–1121. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kang Y, Tiziani S, Park G, Kaul M and
Paternostro G: Cellular protection using Flt3 and PI3Kα inhibitors
demonstrates multiple mechanisms of oxidative glutamate toxicity.
Nat Commun. 5:52014. View Article : Google Scholar
|
|
34
|
Ma S, Henson ES, Chen Y and Gibson SB:
Ferroptosis is induced following siramesine and lapatinib treatment
of breast cancer cells. Cell Death Dis. 7:e23072016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Roh JL, Kim EH, Jang H and Shin D: Nrf2
inhibition reverses the resistance of cisplatin-resistant head and
neck cancer cells to artesunate-induced ferroptosis. Redox Biol.
11:254–262. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R
and Tang D: Activation of the p62-Keap1-NRF2 pathway protects
against ferroptosis in hepatocellular carcinoma cells. Hepatology.
63:173–184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Greenshields AL, Shepherd TG and Hoskin
DW: Contribution of reactive oxygen species to ovarian cancer cell
growth arrest and killing by the anti-malarial drug artesunate. Mol
Carcinog. 56:75–93. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu S, Zhang Q, Sun X, Zeh HJ III, Lotze
MT, Kang R and Tang D: HSPA5 regulates ferroptotic cell death in
cancer cells. Cancer Res. 77:2064–2077. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gao M, Monian P, Pan Q, Zhang W, Xiang J
and Jiang X: Ferroptosis is an autophagic cell death process. Cell
Res. 26:1021–1032. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tang M, Chen Z, Wu D and Chen L:
Ferritinophagy/ferroptosis: Iron-related newcomers in human
diseases. J Cell Physiol. 233:9179–9190. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mancias JD, Wang X, Gygi SP, Harper JW and
Kimmelman AC: Quantitative proteomics identifies NCOA4 as the cargo
receptor mediating ferritinophagy. Nature. 509:105–109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh
HJ III, Kang R and Tang D: Autophagy promotes ferroptosis by
degradation of ferritin. Autophagy. 12:1425–1428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Theil EC: Iron, ferritin, and nutrition.
Ann Rev Nutr. 24:327–343. 2004. View Article : Google Scholar
|
|
44
|
Yang ND, Tan SH, Ng S, Shi Y, Zhou J, Tan
KS, Wong WS and Shen HM: Artesunate induces cell death in human
cancer cells via enhancing lysosomal function and lysosomal
degradation of ferritin. J Biol Chem. 289:33425–33441. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ooko E, Saeed ME, Kadioglu O, Sarvi S,
Colak M, Elmasaoudi K, Janah R, Greten HJ and Efferth T:
Artemisinin derivatives induce iron-dependent cell death
(ferroptosis) in tumor cells. Phytomedicine. 22:1045–1054. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Torii S, Shintoku R, Kubota C, Yaegashi M,
Torii R, Sasaki M, Suzuki T, Mori M, Yoshimoto Y, Takeuchi T and
Yamada K: An essential role for functional lysosomes in ferroptosis
of cancer cells. Biochem J. 15:769–777. 2016. View Article : Google Scholar
|
|
47
|
Haeggström JZ and Funk CD: Lipoxygenase
and leukotriene pathways: Biochemistry, biology, and roles in
disease. Chem Rev. 111:5866–5898. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yin H, Xu L and Porter NA: Free radical
lipid peroxidation: Mechanisms and analysis. Chem Rev.
111:5944–5972. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shah R, Shchepinov MS and Pratt DA:
Resolving the role of lipoxygenases in the initiation and execution
of ferroptosis. ACS Cent Sci. 4:387–396. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Shintoku R, Takigawa Y, Yamada K, Kubota
C, Yoshimoto Y, Takeuchi T, Koshiishi I and Torii S:
Lipoxygenase-mediated generation of lipid peroxides enhances
ferroptosis induced by erastin and RSL3. Cancer Sci. 108:2187–2194.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kuhn H, Banthiya S and van Leyen K:
Mammalian lipoxygenases and their biological relevance. Biochim
Biophys Acta. 1851:308–330. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wipf P, Xiao J, Jiang J, Belikova NA,
Tyurin VA, Fink MP and Kagan VE: Mitochondrial targeting of
selective electron scavengers: Synthesis and biological analysis of
hemigramicidin−TEMPO conjugates. J Am Chem Soc. 127:12460–12461.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ji J, Kline AE, Amoscato A, Samhan-Arias
AK, Sparvero LJ, Tyurin VA, Tyurina YY, Fink B, Manole MD, Puccio
AM, et al: Lipidomics identifies cardiolipin oxidation as a
mitochondrial target for redox therapy of brain injury. Nat
Neurosci. 15:1407–1413. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Krainz T, Gaschler MM, Lim C, Sacher JR,
Stockwell BR and Wipf P: A mitochondrial-targeted nitroxide is a
potent inhibitor of ferroptosis. ACS Cent Sci. 2:653–659. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yen GC and Hsieh CL: Antioxidant effects
of dopamine and related compounds. Biosci Biotechnol Biochem.
61:1646–1649. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Tarazi FI: Neuropharmacology of dopamine
receptors: Implications in neuropsychiatric diseases. J Sci Res Med
Sci. 3:93–104. 2001.PubMed/NCBI
|
|
57
|
Wang D, Peng Y, Xie Y, Zhou B, Sun X, Kang
R and Tang D: Antiferroptotic activity of non-oxidative dopamine.
Biochem Biophys Res Commun. 480:602–607. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yamaguchi Y, Kasukabe T and Kumakura S:
Piperlongumine rapidly induces the death of human pancreatic cancer
cells mainly through the induction of ferroptosis. Int J Oncol.
52:1011–1022. 2018.PubMed/NCBI
|
|
59
|
Trachootham D, Zhou Y, Zhang H, Demizu Y,
Chen Z, Pelicano H, Chiao PJ, Achanta G, Arlinghaus RB, Liu J and
Huang P: Selective killing of oncogenically transformed cells
through a ROS-mediated mechanism by β-phenylethyl isothiocyanate.
Cancer Cell. 10:241–252. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Xiao D, Powolny AA, Moura MB, Kelley EE,
Bommareddy A, Kim SH, Hahm ER, Normolle D, Van Houten B and Singh
SV: Phenethyl isothiocyanate inhibits oxidative phosphorylation to
trigger reactive oxygen species-mediated death of human prostate
cancer cells. J Biol Chem. 285:26558–26569. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Honma Y, Kasukabe T, Yamori T, Kato N and
Sassa T: Antitumor effect of cotylenin a plus interferon-α:
Possible therapeutic agents against ovary carcinoma. Gynecol Oncol.
99:680–688. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Honma Y, Ishii Y, Yamamoto-Yamaguchi Y,
Sassa T and Asahi K: Cotylenin A, a differentiation-inducing agent,
and IFN-alpha cooperatively induce apoptosis and have an antitumor
effect on human non-small cell lung carcinoma cells in nude mice.
Cancer Res. 63:3659–3666. 2003.PubMed/NCBI
|
|
63
|
Honma Y: Cotylenin A-A plant growth
regulator as a differentiation-inducing agent against myeloid
leukemia. Leuk Lymphoma. 43:1169–1178. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Li-Weber M: New therapeutic aspects of
flavones: The anticancer properties of Scutellaria and its main
active constituents wogonin, baicalein and baicalin. Cancer Treat
Rev. 35:57–68. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Kurzatkowski DM and Trombetta LD: Maneb
causes pro-oxidant effects in the hippocampus of Nrf2 knockout
mice. Environ Toxicol Pharmacol. 36:427–436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Qin S, Deng F, Wu W, Jiang L, Yamashiro T,
Yano S and Hou DX: Baicalein modulates Nrf2/Keap1 system in both
keap1-dependent and keap1-independent mechanisms. Arch Biochem
Biophys. 559:53–61. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Sun X, Ou Z, Xie M, Kang R, Fan Y, Niu X,
Wang H, Cao L and Tang D: HSPB1 as a novel regulator of ferroptotic
cancer cell death. Oncogene. 34:5617–5625. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wu C: Heat shock transcription factors:
Structure and regulation. Annu Rev Cell Dev Biol. 11:441–469. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Louandre C, Ezzoukhry Z, Godin C, Barbare
JC, Mazière JC, Chauffert B and Galmiche A: Iron-dependent cell
death of hepatocellular carcinoma cells exposed to sorafenib. Int J
Cancer. 133:1732–1742. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Lachaier E, Louandre C, Godin C, Saidak Z,
Baert M, Diouf M, Chauffert B and Galmiche A: Sorafenib induces
ferroptosis in human cancer cell lines originating from different
solid tumors. Anticancer Res. 34:6417–6422. 2014.PubMed/NCBI
|
|
71
|
Dixon SJ, Patel DN, Welsch M, Skouta R,
Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS
and Stockwell BR: Pharmacological inhibition of cystine-glutamate
exchange induces endoplasmic reticulum stress and ferroptosis.
Elife. 3:e025232014. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Song X, Zhu S, Chen P, Hou W, Wen Q, Liu
J, Xie Y, Liu J, Klionsky DJ, Kroemer G, et al: AMPK-mediated BECN1
phosphorylation promotes ferroptosis by directly blocking system
Xc-activity. Curr Biol. 28:2388–2399. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Bai T, Wang S, Zhao Y, Zhu R, Wang W and
Sun Y: Haloperidol, a sigma receptor 1 antagonist, promotes
ferroptosis in hepatocellular carcinoma cells. Biochem Biophys Res
Commun. 491:919–925. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Yuan H, Li X, Zhang X, Kang R and Tang D:
CISD1 inhibits ferroptosis by protection against mitochondrial
lipid peroxidation. Biochem Biophys Res Commun. 478:838–844. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Chang LC, Chiang SK, Chen SE, Yu YL, Chou
RH and Chang WC: Heme oxygenase-1 mediates BAY 11-7085 induced
ferroptosis. Cancer Lett. 416:124–137. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Louandre C, Marcq I, Bouhlal H, Lachaier
E, Godin C, Saidak Z, François C, Chatelain D, Debuysscher V,
Barbare JC, et al: The retinoblastoma (Rb) protein regulates
ferroptosis induced by sorafenib in human hepatocellular carcinoma
cells. Cancer Lett. 356:971–977. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ou W, Mulik RS, Anwar A, McDonald JG, He X
and Corbin IR: Low-density lipoprotein docosahexaenoic acid
nanoparticles induce ferroptotic cell death in hepatocellular
carcinoma. Free Radic Biol Med. 112:597–607. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Jennis M, Kung CP, Basu S, Budina-Kolomets
A, Leu JI, Khaku S, Scott JP, Cai KQ, Campbell MR, Porter DK, et
al: An african-specific polymorphism in the TP53 gene impairs p53
tumor suppressor function in a mouse model. Genes Dev. 30:918–930.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C,
Dai X, Li Z and Wu G: Ferroptosis: A novel anti-tumor action for
cisplatin. Cancer Res Treat. 50:445–460. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J,
Zhong M, Yuan H, Zhang L, Billiar TR, et al: The tumor suppressor
p53 limits ferroptosis by blocking DPP4 activity. Cell Rep.
20:1692–1704. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Komatsu M, Kurokawa H, Waguri S, Taguchi
K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, et
al: The selective autophagy substrate p62 activates the stress
responsive transcription factor Nrf2 through inactivation of keap1.
Nat Cell Biol. 12:213–223. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Suzuki T, Motohashi H and Yamamoto M:
Toward clinical application of the Keap1-Nrf2 pathway. Trends
Pharmacol Sci. 34:340–346. 2013. View Article : Google Scholar : PubMed/NCBI
|
